Safety and Blood Levels of PMG1016 in Healthy Adults
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new experimental medicine called PMG1016 to see how safe it is and how it moves through the body in healthy volunteers. You'll receive a single dose and have your blood checked and heart monitored to make sure the medicine is well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be in good overall health with no serious medical conditions (heart disease, diabetes, mental health issues, infections, etc.)
- Have a BMI between 17.5–32.0 and weigh 50–100 kg (males) or 45–100 kg (females)
- Normal heart rhythm and blood pressure (heart rate 40–100 bpm, blood pressure below 140/95)
- No use of prescription medications (except birth control) for 2 weeks before the study
- Women: Use two forms of contraception (like condom + birth control pill) and have a negative pregnancy test
- No alcohol, recreational drugs, or recent blood donations; willing to stay at a research clinic for the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
This study is for people who already completed a previous trial of GLM101 for PMM2-CDG. It offers continued access to the treatment while doctors monitor safety and effects.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This trial tests a new investigational drug called CMS-D017 in healthy volunteers. Researchers will give single and multiple doses to see how the body processes it and if it's safe. You could help find an important new treatment.
This study tests a new investigational drug called GV-100 to see how safe it is and how the body handles it. It is for healthy adults and will be given in different doses to find the best one.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.